by admin | May 26, 2021 | Uncategorized
4 June 2021, 1:30-6:30 pm European Academic CAR-T Cells and IECs Clinical Trials: The 1st interactive workshop on practical aspects of CT design and implementation organized by EBMT Cellular Therapy & Immunobiology Working Party (CTIWP), together with the GoCART...
by admin | May 26, 2021 | Uncategorized
22-25 June 2021 9th AIS (Antibody Industrial Symposium): T2EVOLVE will have 2 speakers: from T2 Evolve consortium will be honored to present their work and T2 evolve tasks/ objectives Adoptive cell therapy session: latest advancements – Sonia GuedanEnhancing...
by admin | May 26, 2021 | Uncategorized
15 April 2021, 3-5 pm 1st T2EVOLVE Multistakeholder Meeting: The purpose of this meeting is to engage external stakeholders early in the project, to help shape a T2EVOLVE stakeholder community, and foster opportunities for additional collaborations which...
by admin | May 26, 2021 | Uncategorized
The T2EVOLVE project had its first public appearance at the EHA-EBMT 3rd European CAR T-cell Meeting, with a workshop on February 5, from 7:00 PM CET entitled ‘How to rapidly move new CAR-Ts forward from bench to bedside? Key questions and...
by admin | May 26, 2021 | Uncategorized
T2EVOLVE is a breakthrough alliance of academic and industry leaders in cancer immunotherapy which started in January 2021, under the European Union’s Innovative Medicines Initiative (IMI). The key objective of T2EVOLVE is to accelerate development and to increase...
